An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-7 | Issue 01
Diagnostic Utility of Glycated Hemoglobin (HbA1c) in Newly Diagnosed Type II Diabetes Mellitus Patients
Nisha G. Raval, Ashlesha A. Patel
Published: Jan. 30, 2019 | 49 65
DOI: 10.36347/sjams.2019.v07i01.050
Pages: 283-285
Downloads
Abstract
Nowadays due to sedentary lifestyle and increasing incidence of diabetes, standardized screening test for diagnosis of diabetes mellitus type II is necessary.DM type II is diagnosed by fasting blood sugar, post prandial blood sugar, random blood sugar, oral glucose tolerance test and glycated hemoglobin. In this study we are evaluating the role of HbA1c in diagnosis of type II DM patients by comparing it’s results with RBS, FBS, PP2BS. Observational and prospective study.100 samples are taken since July 2016 to September 2017 who newly diagnosed as type II DM patients came at central clinical laboratory at c.u.shah medical college surendranagar. The results of HbA1c, RBS, FBS and PP2BS for 100 individuals were analysed. There were 100 newly diagnosed type II DM patients respectively.52 of them were females and 48 were males. The mean age of all patients is 43.5 ± 15.5 years. Diagnostic sensitivity of newly diagnosed DM type II by using HbA1c, RBS, FBS and PP2BS 82 %,71 %,51%,36 % respectively. As a Diagnostic tool for newly diagnosed DM II the HbA1c level performed better than RBS, FBS, PP2BS in our study. High diagnostic power of HbA1c may contribute to the decrease in the number of undiagnosed patients.